Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spider venom is a complex mixture of bioactive molecules, including small molecular mass compounds, antimicrobial peptides, cysteine-rich peptide neurotoxins, and proteins/enzymes like phospholipases and proteases. These components target neuronal or neuromuscular signal transduction systems, with key targets including voltage-gated ion channels (NaV, CaV, KCa), lipid bilayers, and NMDA receptors. Venom components exhibit diverse biological activities, such as neurotoxic effects, antimicrobial properties, and insect-selective toxicity. Many spider venom peptides display potent pharmacological activities, rendering them valuable resources for potential therapeutic candidates.
Modulation of ion channel gating, disruption of membrane integrity, enzymatic degradation of phospholipids and extracellular matrix, receptor binding
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spider Venom Components (N/A).